Display options
Cite
Murphy JJ, Hampton JR. Failure of dopexamine to maintain haemodynamic improvement in patients with chronic heart failure. Br Heart J. 1988;60(1):45-9doi: 10.1136/hrt.60.1.45.
Murphy, J. J., & Hampton, J. R. (1988). Failure of dopexamine to maintain haemodynamic improvement in patients with chronic heart failure. British heart journal, 60(1), 45-9. https://doi.org/10.1136/hrt.60.1.45
Murphy, J J, and Hampton, J R. "Failure of dopexamine to maintain haemodynamic improvement in patients with chronic heart failure." British heart journal vol. 60,1 (1988): 45-9. doi: https://doi.org/10.1136/hrt.60.1.45
Murphy JJ, Hampton JR. Failure of dopexamine to maintain haemodynamic improvement in patients with chronic heart failure. Br Heart J. 1988 Jul;60(1):45-9. doi: 10.1136/hrt.60.1.45. PMID: 2900644; PMCID: PMC1216513.
Copy Download .nbib Format: NLM
Share it on
Full text links
HighWire Free PMC Article

Br Heart J. 1988 Jul;60(1):45-9. doi: 10.1136/hrt.60.1.45.

Failure of dopexamine to maintain haemodynamic improvement in patients with chronic heart failure.

British heart journal

J J Murphy, J R Hampton

Affiliations

  1. Department of Medicine, University Hospital, Nottingham.

PMID: 2900644 PMCID: PMC1216513 DOI: 10.1136/hrt.60.1.45
Free PMC Article

Abstract

Ten patients with chronic heart failure were given a continuous infusion of dopexamine after an initial stage of dose titration. On the dose selected the cardiac index initially rose by 56%, as a result of an increase in both heart rate and stroke volume index. Systemic vascular resistance fell by 34% and the mean arterial pressure did not change. Within 18 hours of the start of the continuous infusion, however, all the variables except heart rate had returned to preinfusion values. Nine of the 10 patients were withdrawn from the 48 hour study, six because of haemodynamic deterioration and two because of side effects. If the premature loss of therapeutic effect reflects an intrinsic property of this agent, dopexamine may be of limited clinical value.

Similar articles

References

  1. N Engl J Med. 1974 Oct 3;291(14):707-10 - PubMed
  2. Lancet. 1986 Dec 13;2(8520):1360-3 - PubMed
  3. Circulation. 1977 Sep;56(3):468-72 - PubMed
  4. J Biol Chem. 1978 Mar 10;253(5):1472-80 - PubMed
  5. Am J Med. 1980 Aug;69(2):262-6 - PubMed
  6. N Engl J Med. 1981 Jul 23;305(4):185-90 - PubMed
  7. Am Heart J. 1981 Sep;102(3 Pt 2):500-8 - PubMed
  8. Br J Pharmacol. 1985 Jul;85(3):599-608 - PubMed
  9. Br J Pharmacol. 1985 Jul;85(3):609-19 - PubMed
  10. Br Heart J. 1985 Sep;54(3):313-20 - PubMed
  11. J Clin Invest. 1985 Dec;76(6):2259-64 - PubMed
  12. Am J Med. 1986 Feb 28;80(2B):67-72 - PubMed
  13. Br J Clin Pharmacol. 1986 Apr;21(4):393-400 - PubMed
  14. Eur J Clin Pharmacol. 1986;30(4):485-7 - PubMed
  15. Eur Heart J. 1986 Aug;7(8):697-703 - PubMed
  16. Br J Pharmacol. 1983 Dec;80(4):711-7 - PubMed
  17. Circulation. 1977 Feb;55(2):375-8 - PubMed

Substances

MeSH terms

Publication Types

LinkOut - more resources